XML 18 R17.htm IDEA: XBRL DOCUMENT

C. STOCKHOLDERS EQUITY (Tables)

3 Months Ended

Dec. 31, 2019

Equity [Abstract]

Stock options, stock bonuses and compensation granted by the Company

Name of Plan		Total Shares Reserved Under Plans				Shares Reserved for Outstanding Options				Shares Issued				Remaining Options/Shares Under Plans

Incentive Stock Options Plans			138,400				89,895				N/A				213
Non-Qualified Stock Option Plans			6,387,200				6,129,285				N/A				111,170
Stock Bonus Plans			783,760				N/A				335,700				448,027
Stock Compensation Plan			634,000				N/A				133,908				481,682
Incentive Stock Bonus Plan			640,000				N/A				616,500				23,500

Underlying share information for equity compensation plans as of September 30, 2019 is as follows:

Name of Plan		Total Shares Reserved Under Plans				Shares Reserved for Outstanding Options				Shares Issued				Remaining Options/Shares Under Plans

Incentive Stock Option Plans			138,400				89,895				N/A				213
Non-Qualified Stock Option Plans			6,387,200				6,128,321				N/A				112,166
Stock Bonus Plans			783,760				N/A				331,226				452,501
Stock Compensation Plan			634,000				N/A				130,183				485,407
Incentive Stock Bonus Plan			640,000				N/A				616,500				23,500

Stock option activity

		Three Months Ended December 31,
		2019				2018
Options granted			1,000				500
Options expired			36				2,400

Stock-based compensation expense

		Three months Ended December 31,
		2019				2018
Employees		$	1,800,225			$	573,660
Non-employees		$	155,740			$	238,904

Derivative liabilities, warrants and other options

Warrant/options	Issue Date		Shares Issuable upon Exercise of Warrants/ Options				Exercise Price			Expiration Date		Reference
Series N	8/18/2008			85,339			$	3.00		2/18/2020			*
Series V	5/28/2015			810,127			$	19.75		5/28/2020			*
Series UU	6/11/2018			154,810			$	2.80		6/11/2020			*
Series W	10/28/2015			688,930			$	16.75		10/28/2020			*
Series X	1/13/2016			120,000			$	9.25		1/13/2021			*
Series Y	2/15/2016			26,000			$	12.00		2/15/2021			*
Series ZZ	5/23/2016			20,000			$	13.75		5/18/2021			*
Series BB	8/26/2016			16,000			$	13.75		8/22/2021			*
Series Z	5/23/2016			264,000			$	13.75		11/23/2021			*
Series FF	12/8/2016			68,048			$	3.91		12/1/2021			*
Series CC	12/8/2016			277,463			$	5.00		12/8/2021			*
Series HH	2/23/2017			6,500			$	3.13		2/16/2022			*
Series AA	8/26/2016			200,000			$	13.75		2/22/2022			*
Series JJ	3/14/2017			9,450			$	3.13		3/8/2022			*
Series LL	4/30/2017			26,398			$	3.59		4/30/2022			*
Series MM	6/22/2017			893,491			$	1.86		6/22/2022			*
Series NN	7/24/2017			473,798			$	2.52		7/24/2022			*
Series OO	7/31/2017			40,000			$	2.52		7/31/2022			*
Series RR	10/30/2017			457,116			$	1.65		10/30/2022			*
Series SS	12/19/2017			460,012			$	2.09		12/18/2022			2
Series TT	2/5/2018			459,421			$	2.24		2/5/2023			2
Series VV	7/2/2018			82,500			$	1.75		1/2/2024			*
Consultants	7/28/17			10,000			$	2.18		7/27/2027			3

Tabular disclosure of derivative liabilities at fair value

		December 31, 2019				September 30, 2019
Series V warrants		$	119,411			$	674,442
Series W warrants			1,042,133				1,193,507
Series Z warrants			1,098,996				1,109,545
Series ZZ warrants			62,791				77,638
Series AA warrants			851,930				916,908
Series BB warrants			64,397				63,966
Series CC warrants			1,733,579				1,710,898
Series FF warrants			453,374				446,185
Series HH warrants			45,739				45,657
Series JJ warrants			66,729				66,599
Series LL warrants			182,722				182,965
Total warrant liabilities		$	5,721,801			$	6,488,310

Schedule of gains and (losses) on derivative liabilities

		2019				2018
Series S warrants		$	-			$	33
Series V warrants			555,031				556,332
Series W warrants			151,374				626,850
Series Z warrants			10,549				204,121
Series ZZ warrants			14,847				14,323
Series AA warrants			64,978				157,219
Series BB warrants			(431	)			12,110
Series CC warrants			(22,681	)			665,606
Series DD warrants			-				1,249,287
Series EE warrants			-				1,249,287
Series FF warrants			(7,189	)			69,062
Series GG warrants			-				212,782
Series HH warrants			(82	)			20,951
Series II warrants			-				230,589
Series JJ warrants			(130	)			31,462
Series KK warrants			-				228,095
Series LL warrants			243				28,197
Net gain on warrant liabilities		$	766,509			$	5,556,306

Warrants recorded as equity exercised

Warrants		Warrants Exercised				Exercise Price				Proceeds
Series OO			10,000			$	2.52			$	25,200
Series SS			22,632			$	2.09				47,301
Series TT			100,628			$	2.24				224,600
			132,900							$	297,101

The following warrants recorded as equity were exercised during the three months ended December 31, 2018

Warrants		Warrants Exercised				Exercise Price				Proceeds
Series PP			60,000			$	2.30			$	138,000
Series SS			152,632			$	2.09				319,001
Series TT			86,050			$	2.24				192,752
			298,682							$	649,753

Tabular disclosure of an equity-based arrangement (such as stock or unit options and stock or unit awards) with an individual employee, which is generally an employment contract between the entity and a selected officer or key employee containing a promise by the employer to pay certain equity-based awards at future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares or units issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability.

+ References + Details